Novo Nordisk, Eli Lilly rise after Viking obesity trial data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. ROST
2. WMT
3. AAP
4. FMG:AU
5. AVAH
6. JHX
7. FSUGY
8. ANF
9. HD
10. SPY

Go back to Novo Nordisk, Eli Lilly rise after Viking obesity trial data
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1244.40 --0 (-0%)
Previous Close $1244.40    52 Week High $88.16 
Open $1244.40    52 Week Low $67.88 
Day High $1244.40    P/E 288.06 
Day Low $1244.40    EPS $4.32 
Volume 5,467       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 46.14 --0 (-0%)
Previous Close $46.14    52 Week High $59.00 
Open $46.14    52 Week Low $32.80 
Day High $46.14    P/E N/A 
Day Low $46.14    EPS $0.00 
Volume 355,404       

ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 34.36 --0 (-0%)
Previous Close $34.36    52 Week High $5.17 
Open $34.36    52 Week Low $0.94 
Day High $34.36    P/E N/A 
Day Low $34.36    EPS $0.00 
Volume 3,938